Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism
复制标题
糖尿病、肥胖和新陈代谢
作者:
I. Idris
Non sugar (artificial) sweeteners are used widely to aid weight loss and carbohydrate restriction in people with diabetes. However, there are ongoing uncertainties regarding their long term health risk or benefits due to limited and conflicting studies. A recent review of studies, published in the British Medical Journal have concluded no compelling health benefits of artificial sweeteners, and that potential harm cannot be ruled out. The study analysed 56 studies comparing no intake or lower intake of artificial sweeteners with higher intake in healthy adults and children. Health outcomes included weight, blood sugar levels, oral health, cancer incidence, risk of cardiovascular disease, kidney disease and mood. Assessment of bias was undertaken using standard protocols. Overall, the analysis showed no statistically or clinically relevant differences between those exposed to non-sugar sweeteners and those not exposed, or between different doses of non-sugar sweeteners in terms of the various health outcomes. However, in adults, artificial sweeteners was associated with small improvements in body mass index and fasting blood glucose levels with non-sugar sweeteners, in some small studies, but the certainty of this evidence was low. Interestingly, in children, a smaller increase in body mass index score was seen with artificial sweeteners compared with sugar, but no differences was observed with regards to body weight. No strong evidence was observed of benefits of artificial sweeteners for overweight or obese adults or children who are actively trying to lose weight. Further studies are therefore required to clarify the long term risk benefits of artificial sweeteners in patients with obesity and/or diabetes.